139 related articles for article (PubMed ID: 3926814)
1. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
Hassan-King M; Greenwood BM; Whittle HC
J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
[TBL] [Abstract][Full Text] [Related]
2. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
[TBL] [Abstract][Full Text] [Related]
3. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
Zollinger WD; Mandrell RE
Infect Immun; 1983 Apr; 40(1):257-64. PubMed ID: 6403466
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine.
Milagres LG; Gorla MC; Rebelo MC; Barroso DE
FEMS Immunol Med Microbiol; 2000 Aug; 28(4):319-27. PubMed ID: 10891656
[TBL] [Abstract][Full Text] [Related]
5. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
[TBL] [Abstract][Full Text] [Related]
6. [Immunity against Neisseria meningitidis in different population groups].
Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
[TBL] [Abstract][Full Text] [Related]
7. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.
Ceesay SJ; Allen SJ; Menon A; Todd JE; Cham K; Carlone GM; Turner SH; Gheesling LL; DeWitt W; Plikaytis BD
J Infect Dis; 1993 May; 167(5):1212-6. PubMed ID: 8486957
[TBL] [Abstract][Full Text] [Related]
8. Evidence for familial immune defect in meningococcal meningitis.
Whittle HC; Oduloju A; Evans-Jones G; Greenwood BM
Br Med J; 1976 May; 1(6020):1247-50. PubMed ID: 817771
[TBL] [Abstract][Full Text] [Related]
9. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
10. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.
Arakere G; Frasch CE
Infect Immun; 1991 Dec; 59(12):4349-56. PubMed ID: 1937795
[TBL] [Abstract][Full Text] [Related]
11. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
Ambrosch F; Wiedermann G; Crooy P; George AM
Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
[TBL] [Abstract][Full Text] [Related]
13. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
[TBL] [Abstract][Full Text] [Related]
14. Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy.
D'Amelio R; Agostoni A; Biselli R; Brai M; Caruso G; Cicardi M; Corvetta A; Fontana L; Misiano G; Perricone R
Scand J Immunol; 1992 May; 35(5):589-95. PubMed ID: 1579859
[TBL] [Abstract][Full Text] [Related]
15. Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals.
Schlesinger M; Kayhty H; Levy R; Bibi C; Meydan N; Levy J
J Clin Immunol; 2000 Jan; 20(1):46-53. PubMed ID: 10798607
[TBL] [Abstract][Full Text] [Related]
16. Status of a group B Neisseria meningitidis vaccine.
Frasch CE
Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
[No Abstract] [Full Text] [Related]
17. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
[TBL] [Abstract][Full Text] [Related]
19. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
Granoff DM; Gupta RK; Belshe RB; Anderson EL
J Infect Dis; 1998 Sep; 178(3):870-4. PubMed ID: 9728562
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
Zollinger WD; Moran EE; Devi SJ; Frasch CE
Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
